Steve Q. Yang, Ph.D
COO, EVP & Head of IDSU
Dr. Steve Yang is Executive Vice President and Chief Operating Officer of WuXi AppTec. He is also WuXi’s Head of International Discovery Services Unit (IDSU). WuXi AppTec (NYSE: WX) is a leading global pharmaceutical, biopharmaceutical, and medical device R&D capability and technology open access platform company with operations in China and the United States.
Dr. Yang is a pharmaceutical industry leader recognized for building R&D capabilities, delivering research and early development portfolios of drug candidates, and establishing R&D partnerships in China and other Asian and emerging markets. Before joining WuXi, Dr. Yang was Vice President and Head of Asia and Emerging Markets iMed at AstraZeneca, based in Shanghai. Previously, Dr. Yang served as Vice President and Head of Asia R&D at Pfizer based in Shanghai, and as Executive Director and head of Pfizer’s global R&D strategic management group based in the United States. Before joining Pfizer, Dr. Yang held a number of leadership positions at IntraBiotics Pharmaceuticals, a U.S.-based biotech company.
Dr. Yang received his PhD in Pharmaceutical Chemistry from the University of California, San Francisco. He started his undergraduate study in Fudan University, China and completed his BS Summa Cum Laude from Michigan Technological University.